Literature DB >> 10791199

Cost-effectiveness analysis of immunochemical occult blood screening for colorectal cancer among three fecal sampling methods.

M Yamamoto1, H Nakama.   

Abstract

BACKGROUND/AIMS: To evaluate the optimal sampling times of stool in immunochemical occult blood screening from the viewpoint of the cost-effectiveness.
METHODOLOGY: A colorectal cancer screening was conducted in 5 municipalities (Matsumoto, Hata, Yamagata, Asahi, Sakai), Nagano prefecture, Japan in 1996. Each participant received a fecal occult blood test with 3 consecutive days. For the economic assessment of testing methods, the results of the 1st day, those of the 1st and 2nd days and those of the 3 consecutive days were used for a single-day method, a 2-day method, and a 3-day method. The average costs per detection of one cancer patient and diagnostic validity were evaluated among 3 months.
RESULTS: The average costs for one cancer case detected were calculated to be $5924 for a single-day method, $6014 for a 2-day method, and $7123 for a 3-day method, respectively. The sensitivity and specificity were calculated to be 58% and 96% for a single-day method, 89% and 95% for a 2-day method, and 100% and 94% for a 3-day method, respectively, indicating a significant difference in the sensitivity between a single-day method and a 2-day as well as a 3-day method (P < 0.05), and in the specificity among 3 testing methods (P < 0.001).
CONCLUSIONS: The present analysis suggests that a 2-day collection method is recommended in the immunochemical occult blood screening from the viewpoint of the cost-effectiveness as well as the diagnostic accuracy.

Entities:  

Mesh:

Year:  2000        PMID: 10791199

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  5 in total

1.  Free Fecal Immunochemical Test Disbursement in Eight Family Physician Offices.

Authors:  Jeanette M Daly; Barcey T Levy; Yinghui Xu
Journal:  J Community Health       Date:  2015-10

2.  Screening techniques for prevention and early detection of colorectal cancer in the average-risk population.

Authors:  Hana Strul; Nadir Arber
Journal:  Gastrointest Cancer Res       Date:  2007-05

3.  Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening.

Authors:  S Lucas Goede; Aafke H C van Roon; Jacqueline C I Y Reijerink; Anneke J van Vuuren; Iris Lansdorp-Vogelaar; J Dik F Habbema; Ernst J Kuipers; Monique E van Leerdam; Marjolein van Ballegooijen
Journal:  Gut       Date:  2012-04-05       Impact factor: 23.059

4.  Sensitivity of latex agglutination faecal occult blood test in the Florence District population-based colorectal cancer screening programme.

Authors:  G Castiglione; C B Visioli; S Ciatto; G Grazzini; A G Bonanomi; T Rubeca; P Mantellini; M Zappa
Journal:  Br J Cancer       Date:  2007-04-24       Impact factor: 7.640

5.  Detection of advanced colorectal neoplasia and relative colonoscopy workloads using quantitative faecal immunochemical tests: an observational study exploring the effects of simultaneous adjustment of both sample number and test positivity threshold.

Authors:  Graeme P Young; Richard J Woodman; Erin Symonds
Journal:  BMJ Open Gastroenterol       Date:  2020-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.